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This review article focuses on the morphological and functional alterations that characterize
patients with myocardial bridges (MB) as well as the currently available diagnostic and
treatment strategies. Because of incomplete understanding of the pathophysiology of MB,
their clinical significance has been the subject of debate for the last quarter century.
Investigational tools now available in the cardiac catheterization laboratory have helped clarify
why symptoms and signs of ischemia can occur in such patients, especially when the only
angiographic finding appears to be systolic compression or milking effect of a coronary vessel.
Quantitative coronary angiography and intravascular ultrasound (IVUS) clearly demonstrate
that the phasic systolic vessel compression visualized on the angiogram is coupled with a
persistent diastolic diameter reduction. Intracoronary Doppler reveals increased flow veloci-
ties, retrograde systolic flow, and reduced coronary flow reserve. The clinical diagnosis can be
established by significant percent lumen diameter and area narrowing, increased flow velocity,
and by characteristic patterns such as the “half moon” phenomenon on IVUS and the early
diastolic “finger tip” phenomenon on intracoronary Doppler. Successful medical, interven-
tional, or surgical therapy leads not only to marked improvement or normalization of these
alterations but also relief of angina and ischemia. (J Am Coll Cardiol 2003;41:351–9)
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In 1976, we described pacing-induced angina and myocar-
dial ischemia in a group of patients with isolated myocardial
bridging of the left anterior descending coronary artery
(LAD) documented at coronary angiography by a milking
effect or transient constriction of the artery during systole
(1) (Fig. 1). During the next 15 to 20 years, the clinical,
hemodynamic, and prognostic significance of this entity has
remained controversial, some investigators suggesting that it
was a benign condition (2–4), and others reporting a variety
of acute coronary syndromes associated with them (5–10).
However, important new diagnostic tools have become
available in the last decade that have greatly contributed in
establishing the clinical relevance of myocardial bridging
(11–16). This report reviews the morphological and hemo-
dynamic findings derived from these new diagnostic modal-
ities as well as the functional significance and therapeutic
options of this intriguing clinical entity.
INCIDENCE OF MYOCARDIAL BRIDGING
Myocardial bridging occurs when a band of cardiac muscle
overlies an intramural segment of a coronary artery, the
intramural segment being referred to as a “tunneled” artery.
Usually, the coronary vessels course over the epicardial
surface of the heart but may dip into the myocardium for
varying lengths and then reappear on the heart’s surface.
The LAD is by far the vessel most often overbridged;
however, diagonal branches are occasionally involved as well
as the posterior descending right coronary artery or marginal
branches of the circumflex artery.
Although myocardial bridges (MB) were initially recog-
nized by Reyman in 1737 (17) and later by Black in 1805
(18), the first detailed postmortem analysis of a series of
patients with this anomaly was reported by Geiringer in
1951 (19). In 1960, Portmann and Iwig (20) published the
first radiological description of a transient occlusion in a
segment of the LAD during systole. In 1976, we described
a milking effect or transient narrowing of the LAD during
systole in 27 (0.5%) of 5,250 patients having undergone
selective coronary angiography (1). Since then, a wide
discrepancy has existed between pathological series, in
which the incidence of MB has been reported to vary
between 15% and 85% (21–24), and angiographic series in
which it ranges from 0.5% to 2.5% (1–4).
This large discordance suggests that only a minority of
patients with MB are in fact at increased risk for clinical
symptoms and cardiac events. Moreover, among patients
with angiographically documented milking effect or systolic
narrowing of a coronary artery, a fairly large percentage
(roughly half in our series of 27 patients) have concomitant
atherosclerotic, muscular, or valvular heart disease, which
independently affect clinical outcome as well as treatment
strategy (1). Finally, among patients with isolated MB
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documented at angiography, only about two-third exhibit a
50% narrowing of the vessel during systole (1).
MECHANISMS OF MYOCARDIAL
ISCHEMIA IN PATIENTS WITH SYMPTOMATIC MB
Until recently, visual interpretation of coronary angiograms
only revealed the milking effect or systolic narrowing in-
duced by significant myocardial bridging of a coronary
artery. However, it is well recognized that coronary flow
occurs predominantly during the diastolic phase of the
cardiac cycle. Therefore, it appeared unlikely that this
systolic phenomenon could by itself result in myocardial
ischemia. Although a delay in diastolic relaxation of the
coronary vessel was suspected in these patients, its presence
was hard to demonstrate on the coronary angiogram. In
1981, in a frame-by-frame analysis of cine-angiograms
during a complete cardiac cycle, we were able to demon-
strate that 17 of 20 patients (85%) with a 75% milking
effect of the LAD (by visual inspection) had an extension of
the obstruction into diastole, which averaged 136 ms or 26%
(range 4% to 50%) of diastole (25). In 1986, Navarro-Lopez
et al. (26) also showed a time-lag of up to one-third of
diastole before flow returned to normal following systolic
compression. In an elegant study published in 1983, Rou-
leau et al. (27) demonstrated that transient systolic com-
pression of the left circumflex coronary artery in dogs
resulted in a diastolic time lag of 69  4 ms, which was
needed to repressurize the distal coronary bed and which
could become the limiting factor for myocardial perfusion
during tachycardia and maximal coronary vasodilation.
Finally, Pichard et al. (28) reported a significant transient
decrease in great cardiac vein flow during atrial pacing in
patients with myocardial bridging of the LAD, and they
attributed this flow reduction to a reduced time period of
diastole (compared to systole) during tachycardia. However,
it was not until the current era of new investigational
modalities such as quantitative coronary angiography
(QCA), intravascular ultrasound (IVUS), and intracoronary
Doppler flow velocity measurements that we were able to
better understand the hemodynamic disturbances occurring
during the diastolic phase of the cardiac cycle in patients
with MB (11–16).
On the basis of these recent studies, two mechanisms are
responsible for reduced coronary flow reserve (CFR) in the
distal vessel and for clinical symptoms and signs of myocar-
dial ischemia: 1) a phasic systolic vessel compression with
persistent mid-to-late diastolic diameter reduction and 2)
increased intracoronary Doppler flow velocities with abnor-
mal qualitative flow profiles.
Coronary diameter reduction. Table 1 summarizes the
QCA findings in four different series of patients with
symptomatic MB and 50% diameter narrowing of the
LAD by visual inspection. The percent mean lumen diam-
eter (MLD) reduction in the most severe view of the MB
during systole ranged from 71% to 83%, and there was a
persistent mean diastolic MLD reduction from 34% to 41%.
These luminal narrowings were confirmed by cross-
sectional area measurements using IVUS (15). The average
length of the MB during systole ranged from 23 to 28 mm
and was not different from the diastolic values of 22 to 27
mm.
Abbreviations and Acronyms
AMI  acute myocardial infarction
ADPV  average diastolic peak flow velocity
APV  average peak flow velocity
ASPV  average systolic peak flow velocity
CFR  coronary flow reserve
DSVR  diastolic/systolic flow velocity ratio
IVUS  intravascular ultrasound
LAD  left anterior descending coronary artery
MB  myocardial bridge(s)
MLD  mean lumen diameter
MPV  maximal peak flow velocity
PCI  percutaneous coronary intervention
QCA  quantitative coronary angiography
Figure 1. Coronary angiogram of a patient with myocardial bridging of the
left anterior descending coronary artery in the right anterior oblique
position. (A) An absence of constriction during diastole is shown. (B) This
depicts the “milking effect” during systole (arrow).
352 Bourassa et al. JACC Vol. 41, No. 3, 2003
Symptomatic Myocardial Bridges: An Overview February 5, 2003:351–9
Increased intracoronary Doppler flow velocities. As
shown in Table 2, resting average peak-flow velocity (APV)
and average diastolic peak flow velocity (ADPV) were
higher within the bridged segment than in the correspond-
ing proximal and distal segments. The flow velocity increase
within the MB was smallest for the average systolic peak
flow velocity (ASPV). Instantaneous maximal peak flow
velocity (MPV) was more than twice as high within the
bridged segment as compared to the proximal and distal
segments. Mean diastolic/systolic flow velocity ratio
(DSVR) at rest ranged from 2.4 to 2.9. Thus, intracoronary
Doppler flow measurements reveal a significant increase in
APV, ADPV, and MPV within the MB at rest, with only
minor changes in systolic flow. These flow velocity abnor-
malities are very consistent across the different studies.
During rapid atrial pacing (Table 3), all flow velocities
Table 1. Quantitative Coronary Angiography in Patients With Symptomatic Myocardial Bridges
Schwarz et al. (12)
n  15
Schwarz et al. (13)
n  42
Klues et al. (14)
n  12
Haager et al. (16)
n  11
Systolic MLD (mm)
Proximal 2.7  0.5 3.1  1.3 2.8  0.3 2.3  0.5
Distal 2.2  0.4 2.5  0.8 2.2  0.3 1.8  0.4
Within MB 0.7  0.3 0.8  0.6 0.5  0.2 0.6  0.3
% Diameter reduction
Mean (SD) 83  9 71  16 81  9 74  12
Range 71–99 — — 55–89
Mid-diastolic MLD (mm)
Proximal 2.6  0.5 3.0  1.0 2.9  0.5 —
Distal 2.4  0.4 2.5  0.8 2.2  0.3 —
Within MB 1.7  0.3 1.7  0.4 1.6  0.4 1.4  0.4
% Diameter reduction
Mean (SD) 41  11 35  13 35  11 34  10
Range 24–58 18–69 — 22–58
Length of MB (mm)
Systolic
Mean (SD) 27  8 23  8 28  4 25  2
Range 19–44 11–44 — 13–36
Diastolic
Mean (SD) 25  5 22  7 27  5 —
Range 21–42 — — —
MB  myocardial bridge; MLD  mean lumen diameter; SD  standard deviation.
Table 2. Intracoronary Doppler Flow Velocity Measurements at Rest in Patients With Symptomatic Myocardial Bridges
Schwarz et al. (12)
n  15
Schwarz et al. (13)
n  42
Klues et al. (14)
n  12
Ge et al. (15)
n  48
Haager et al. (16)
n  11
APV (cm/s)
Proximal 21.2  7.4 18.3  5.3 13.5  4.9
Distal 14.3  3.2 15.6  3.7 12.2  4.9
Within MB 26.7  9.6 30.6  16.0 27.0  13.6 19.0  7.9 35.0  4.0
ASPV (cm/s)
Proximal 12.3  4.6 10.2  4.3 6.1  3.7
Distal 9.1  2.3 9.6  3.0 6.5  3.3
Within MB 13.7  6.6 14.0  5.2 14.7  9.8
ADPV (cm/s)
Proximal 25.5  13.3 22.4  7.7 17.3  5.7
Distal 16.5  3.6 18.6  4.6 15.2  6.3
Within MB 33.1  13.4 38.6  19.0 31.5  14.3
MPV (cm/s)
Proximal 31.5  13.5 33.5  9.6 28.6  8.8
Distal 24.3  11.6 29.3  7.8 24.7  14.4
Within MB 78.1  21.1 70.5  33.7 63.7  26.2 43.2  18.7
DSVR
Proximal — 2.2  0.6
Distal — 2.0  0.5
Within MB 2.4  1.0 2.5  1.2 2.9  1.4
CFR
Proximal 2.7  0.8 2.9  0.9
Distal 2.0  0.6 2.3  0.05 2.5  0.5 2.03  0.54 2.6  0.5
ADPV  average diastolic peak flow velocity; APV  average peak flow velocity; ASPV  average systolic peak flow velocity; CFR  coronary flow reserve; DSVR 
diastolic/systolic flow velocity ratio; MB  myocardial bridge; MPV  maximal peak flow velocity.
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within the MB were increased. The flow acceleration was
largest for MPV and again smallest for ASPV within the
bridge segment. There was a significant increment in DSVR
within the MB during tachycardia, but no change proxi-
mally or distally. Thus, atrial pacing induced a further
acceleration in flow velocities within the bridged segment,
whereas the flow velocities proximal and distal to the bridge
remained unchanged. A significant increase in DSVR ap-
pears to be the most prominent flow alteration within the
MB during stress. Finally, qualitative analysis of the Dopp-
ler flow profile shows a highly characteristic pattern in
approximately 90% of the patients with an abrupt early
diastolic flow acceleration, which has been termed the
“finger tip” phenomenon, a rapid mid-diastolic deceleration
and mid-to-late diastolic plateau (Fig. 2). A retrograde flow
phenomenon during systole was detected in the majority of
patients at the proximal entry site of the bridged segments.
Atrial pacing led to further accentuation of the velocity
profile, with shortening of the diastolic plateau as well as
accentuation of the retrograde flow phenomenon.
Schwarz et al. (13) quantitatively analyzed consecutive
stop-frame images from a complete heart cycle in 14
patients and correlated their results with Doppler flow
measurements obtained in the same patients at an identical
site. There was rapid lumen reduction during systole with
the smallest diameter during late systole, the characteristic
milking effect. Early diastolic diameter gain was clearly
delayed with a persistent mid-diastolic diameter reduction
always 30%. The abrupt early diastolic flow acceleration
was due to this persistent diastolic diameter reduction. This
was followed by rapid diastolic lumen gain, which reduced
the flow velocity, and finally stabilization of the lumen
diameter leading to a plateau during late diastole. As shown
by this study, the speed of early diastolic diameter gain and
systolic compression strongly depends on heart rate, con-
tractile state, and peripheral resistance and may vary sub-
stantially.
CFR. The CFR, defined as the ratio of mean flow velocity
achieved at peak hyperemia to mean resting flow velocity,
was obtained after intracoronary injection of papaverine. A
normal CFR ratio should be above 3.0. Thus, CFR distal to
the bridge was abnormally reduced in all these studies,
ranging from 2.0 and 2.6 (Table 2). Impaired CFR can be
explained, besides systolic vessel compression, by the de-
layed early and mid-diastolic relaxation with increased
diastolic blood flow velocities. The increase in CFR ob-
tained after angioplasty of the bridge segment is described in
the following text.
Additional mechanisms of myocardial ischemia. Several
additional factors have been shown to influence both the
degree of systolic compression and the speed of early
Table 3. Intracoronary Doppler Flow Velocity Measurements
During Atrial Pacing in Patients With Symptomatic
Myocardial Bridges
Schwarz et al. (12)
n  15
Schwarz et al. (13)
n  42
APV (cm/s)
Proximal 29.1  12.2 20.3  6.0
Distal 20  4.2 17.0  4.5
Within MB 63.3  21.3 46.3  20.0
ASPV (cm/s)
Proximal 10.9  3.4 10.9  3.9
Distal 9.1  4.0 10.0  4.2
Within MB 16.2  7.0 15.8  7.5
ADPV (cm/s)
Proximal 29.1  12.2 27.1  9.5
Distal 20.2  4.2 22.7  6.6
Within MB 63.3  21.3 64.7  25.0
MPV (cm/s)
Proximal 34.4  8.0 39.8  12.3
Distal 27.8  8.4 33.8  8.8
Within MB 104.8  35.7 104.7  36.7
DSVR
Proximal 2.3  0.4
Distal 2.7  1.0
Within MB 4.9  2.9 4.4  2.8
Abbreviations as in Table 2.
Figure 2. Intracoronary Doppler blood flow velocity profile showing the characteristic “finger-tip”-like flow velocity acceleration during early diastole
(single arrow) followed by a plateau phase at mid-to-late diastole (arrows in A and B). During systole, there is almost no flow within the bridged segment,
but a retrograde flow phenomenon occurs at the entry site of the myocardial bridge (arrows in A). During rapid atrial pacing, absolute diastolic flow
velocities are increased, and the duration of the plateau phase is reduced owing to shortened diastole (C). Reproduced from Schwarz et al. (13), with
permission.
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diastolic gain and subsequent diastolic relaxation in patients
with symptomatic MB (Table 4). They include anatomical
variables such as length, thickness, and location of the
muscle bridge and presence or absence of left ventricular
hypertrophy as well as physiological factors such as in-
creased heart rate, low systolic arterial pressure, coronary
vasomotion, and enhanced platelet aggregation.
Both autopsy and angiography reports have shown that
the length of MB varies widely (from 4 to 40 mm)
(1–4,21–24). As shown experimentally, the length of a
coronary arterial narrowing markedly influences coronary
hemodynamics (29). This may explain why relatively long
bridges are observed in symptomatic patients (Table 1). In
autopsy reports, the thickness of the bridge also varies
widely (from 1 to 4 mm) (21–24). Intravascular ultrasound
studies confirm that the thicker bridges are most frequently
observed in symptomatic patients (15). As shown by Fer-
reira et al. (24), the location and orientation of the muscle
bundles over the imbedded coronary artery also affect
systolic compression. Many bridges are superficial, crossing
the vessel transversely toward the apex of the heart. Others
are deeper muscle bridges surrounding the mid or even the
proximal LAD. Finally, left ventricular hypertrophy, hyper-
trophic cardiomyopathy, and aortic stenosis are not infre-
quently associated with symptomatic MB, and a progressive
increase in left ventricular wall tension may explain at least
in part why MB present from birth produces symptoms only
later in life (1,6,7,30).
Other important factors include the effect of heart rate
(1,5,12,13,31) and systemic blood pressure (32,33) on mus-
cular bridges. With slow-resting heart rate, most coronary
blood flow occurs in diastole. However, at high heart rates,
the diastolic period is significantly shortened. Intracoronary
Doppler measurements show that diastolic flow velocity
disturbances predominate in patients with symptomatic MB
during rapid atrial pacing (Table 3). Changes in systemic
arterial pressure and coronary perfusion pressure can also
significantly affect the severity of systolic and consequently
of early and mid-to-late diastolic compression in patients
with MB. For example, sublingual or intracoronary nitro-
glycerin and sodium nitroprusside increase the coronary
narrowing in patients with MB, whereas noradrenaline,
phenylephrine, and ergonovine decrease it (4,31,33).
As an alternative mechanism, vasospastic coronary con-
striction may be associated with MB (9,34–36). The systolic
milking of the vessel may produce, especially at high heart
rates, endothelial damage, which may stimulate platelet
aggregation and coronary vasospasm. Interestingly, how-
ever, several investigators have reported an absence of
atherosclerotic changes both at the level of intramural
coronary arteries and in the distal segment of the bridge at
autopsy, as well as at coronary angiography (4,19,23,24),
and this has been confirmed by IVUS (11,15). The mech-
anisms responsible for this protective effect are poorly under-
stood. In contrast, it has been postulated that the systolic
compression may increase the trauma sustained by the intima
proximal to the bridge (11,21,23). Ge et al. (11), using IVUS,
found atherosclerotic plaques in the segment proximal to the
bridge in 12 of 14 patients (86%). In a subsequent IVUS study
(15), significant stenoses were documented in 12 of 69 pa-
tients; these 12 patients subsequently underwent percutaneous
coronary intervention (PCI).
CLINICAL MANAGEMENT OF
PATIENTS WITH SYMPTOMATIC MB
Clinical symptoms and objective signs of myocardial
ischemia. Myocardial bridges can be an incidental finding
at the time of coronary angiography. Conversly, a wide
variety of clinical syndromes including unstable angina,
acute myocardial infarction (AMI), life-threatening cardiac
arrhythmias, and sudden cardiac death have been associated
with MB (5–10). Likewise, following our initial publication
in 1976 (1), several series of symptomatic patients have been
reported (2–4,11–16). Table 5 lists the demographic and
clinical characteristics of patients with symptomatic MB in
six recent studies (11–16). Typically, these patients are
predominantly males, 5 to 10 years younger than patients
with symptomatic coronary disease, and they have fairly
severe anginal symptoms. Typical angina is present in 55%
to 70% of the cases, and atypical angina is often reported in
association with rest angina. The mean time interval be-
tween onset of symptoms and coronary angiography is 18
months, and there were an average of 2.5 previous hospital
admissions for angina or suspected AMI. Some patients had
documented prior anterior or septal non–Q-wave AMI.
Except for 12 patients (18%) of Ge et al. (15) who had
significant stenoses in the proximal segment of the bridged
artery, all these selected patients had isolated MB with
50% systolic lumen diameter reduction, without angio-
graphic evidence of significant coronary atherosclerosis or
left ventricular hypertrophy.
Symptom-limited exercise electrocardiograms were per-
formed in 73% to 100% of patients. As a rule, patients not
undergoing stress testing before cardiac catheterization had
unstable symptoms. Significant ischemic ST-segment de-
pression 0.1 mV in the anterior leads was identified in
28% to 67% of patients in whom the test was done.
Myocardial scintigraphy was obtained in 38% to 100% of
patients. Stress-induced perfusion defects of the anterior
wall or septum were documented in 33% to 63% of the
patients in whom the myocardial scan was performed.
Table 4. Factors Influencing the Occurrence of Myocardial
Ischemia in Patients With Symptomatic Myocardial Bridges
Anatomical factors
Length, thickness, and localization of the myocardial bridge
Presence or absence of left ventricular hypertrophy
Physiological factors
Increased heart rate
Low systemic arterial pressure
Coronary vasoconstriction
Enhanced platelet aggregation
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Therefore, compared to patients with significant single-
vessel coronary disease, these selected patients with isolated
symptomatic myocardial bridging and 50% systolic lumen
diameter narrowing of the LAD probably exhibit a compa-
rable severity of anginal symptoms and of noninvasive signs
of myocardial ischemia. This probably also includes a
similar incidence of prior or recent unstable angina and
AMI. Finally, the long-term outcome of these patients may
also be as favorable as that of patients with single-vessel
coronary disease or even better, because, in contrast to
atherosclerosis, little late progression is to be expected.
Invasive diagnostic methods. Quantitative coronary an-
giography, usually in the plane showing the most severe
narrowing, objectively measures the lumen diameter reduc-
tion within the bridge segment as compared to the proximal
and distal segments and determines the percent MLD
narrowing both during systole and during mid-to-late dias-
tole. As a rule, a significant milking effect shows a 70%
MLD reduction during systole and a 35% MLD reduc-
tion during mid-to-late diastole (Table 1). The severity of
the systolic and mid-to-late diastolic MLD narrowing can
be confirmed by IVUS, which has the advantage of assessing
lumen area instead of only diameter in an invariably non-
spherical vessel lumen. Ge et al. (15) have described a highly
specific “half moon” phenomenon surrounding the MB in
all 62 patients in whom the IVUS catheter could be passed
through the bridge segment (Fig. 3). This ultrasound
phenomenon is only found in the bridge segment and not in
the proximal or distal segment or in other coronary arteries.
In some cases where the specific “half moon” phenomenon
was demonstrated but the typical angiographic milking
effect was not obvious presumably because of only slight
myocardial bridging, the milking effect could be provoked
by intracoronary administration of nitroglycerin.
Intracoronary Doppler flow velocity measurements reveal
another highly characteristic diagnostic pattern in patients
with MB. In approximately 90% of cases, the flow velocity
curve within the bridge segment is characterized by an early
diastolic “finger tip” phenomenon, followed by a rapid
mid-diastolic deceleration and a mid-to-late diastolic pla-
teau (Fig. 2). The typical “finger tip” phenomenon is
produced by an abrupt early diastolic flow acceleration as a
result of delayed vessel relaxation within the bridge seg-
ment. As a result of the systolic compression, there is also a
markedly reduced to absent antegrade systolic flow and
quite often a typical local systolic retrograde flow phenom-
enon directly proximal to the more severe site of the MB.
Rapid atrial pacing accentuates these characteristic early
diastolic and retrograde systolic flow phenomena while it
also shortens the mid-to-late diastolic plateau (Fig. 2).
Typically, intracoronary Doppler flow velocities at rest,
especially APV, ADPV, and MPV should be higher in the
bridge segment than in the proximal and distal segments
and they should be accentuated by rapid atrial pacing
(Tables 2 and 3). Finally, a 3.0 CFR distal to the MB
obtained after intracoronary administration of papaverine
reflects a hemodynamically significant mid-to-late diastolic
coronary flow reduction as a result of the increased resis-
tance produced by the MB (Table 2).
Table 5. Demographic and Clinical Characteristics of Patients With Symptomatic Myocardial Bridges
Ge et al. (11)
n  14
Schwarz et al. (12)
n  15
Schwarz et al. (13)
n  42
Klues et al. (14)
n  12
Ge et al. (15)
n  69
Haager et al. (16)
n  11
Age (yrs)
Mean (SD) 58  9 52.6  6.8 53.4  8 44  6 52  10 52  12
Range 47–69 39–63 35–69
Gender (male) 12 (86%) 13 (87%) 35 (83%) 54 (78%) 10 (91%)
Interval symptoms/diagnosis (mon)
Mean (SD) 19.7  21 18.4  24
Range 1–88 1–96
No. of hospital admissions
Mean (SD) 2.5  1.3 2.5  1.4 2.5  1.0
Angina pectoris
Overall 14 (100%) 15 (100%) 42 (100%) 12 (100%) 69 (100%) 11 (100%)
Typical 10 (67%) 6 (55%)
Atypical 5 (33%) 5 (45%)
CCS class
II 5 (33%) 2 (18%)
III 6 (40%) 9 (82%)
IV 4 (27%)
Exercise stress testing
Total 11 (73%) 35 (83%) 12 (100%) 64 (93%) 11 (100%)
Positive 7 (64%) 21 (60%) 8 (67%) 18 (28%) 4 (36%)
Myocardial scintigraphy
Total 8 (53%) 16 (38%) 43 (62%) 11 (100%)
Positive 5 (63%) 10 (63%) 14 (33%) 6 (55%)
Coronary disease on angiography None None None None 12 (18%) None
LV hypertrophy None None None None None —
CCS  Canadian Cardiovascular Society; LV  left ventricular; SD  standard deviation.
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Therapeutic options. On the basis of the previous patho-
physiological and clinical observations, three different treat-
ment strategies, medical therapy, PCI, and direct surgical
myotomy or coronary bypass grafting, might be beneficial in
these patients. Obviously, medical therapy should be the
first and principal strategy, and interventions should be
limited to patients with refractory angina despite medical
therapy. Finally, these treatment options are not strikingly
different from those of patients with single-vessel coronary
disease, and especially those with single LAD disease.
Medical therapy. Symptomatic patients with myocardial
bridging must be treated. Medical therapy should include
optimal doses of beta-blockers, calcium channel blockers,
and antiplatelet agents with the objective of relieving symp-
toms and signs of myocardial ischemia and/or protecting
against the risk of future coronary events. Negative inotropic
and chronotropic agents, especially beta-adrenergic receptor
blockers, can reduce external vessel compression by lowering
systemic and intramural pressures and can improve coronary
perfusion by prolonging the period of diastole (37,38).
Schwarz et al. (12) demonstrated that the administration of
a short-acting beta-blocker during atrial pacing alleviated
symptoms and signs of ischemia in patients with symptom-
atic MB. This effect was mediated by a significant reduction
in systolic and diastolic vascular compression as well as a
significant reduction in mid-to-late diastolic flow velocities
within the bridged segments with a normalization of both
DSVR and CFR. Calcium channel blockers have been less
often used in these patients (38). They may be particularly
useful when there is a contraindication to beta-blocker
therapy or as primary therapy when coronary vasospasm is
suspected. Nitrates have been used effectively in some
patients, possibly because of their capability to reduce
preload and to relieve vasospasm (28), although they have
been shown to increase the milking effect on angiography
mainly as a result of coronary and systemic vasodilation with
increased heart rate, cardiac contraction, and reduced cor-
onary pressure distal to the bridged segment (32,33). Fi-
nally, in most symptomatic patients, limitation of strenuous
physical activity is usually indicated to avoid the deleterious
effect of tachycardia.
PCI. Stables et al. (39) first demonstrated, in 1995, that
intracoronary stent implantation could achieve internal sta-
bilization of the coronary artery lumen against external
compression in a patient with a muscular bridge. In 1997,
Klues et al. (14) reported hemodynamic, angiographic, and
IVUS data immediately and seven weeks after successful
coronary stent implantation in three symptomatic patients.
Stent placement abolished the phasic lumen compression,
the diastolic flow abnormalities, and clinical symptoms. The
CFR improved from 2.4  0.5 to 3.8  0.3. Coronary
angiography after seven weeks revealed an identical lumen
enlargement without any systolic or diastolic diameter
reduction and a further increase in CFR. Intravascular
ultrasound revealed no signs of neointimal proliferation
within or proximal or distal to the stented segments. All
patients reported remarkable clinical improvement, with
increased physical activity. Favorable short-term clinical and
angiographic results after coronary stenting were also re-
ported by others (40,41). Haager et al. (16) recently de-
scribed successful coronary stenting in 11 patients who
subsequently underwent repeat coronary angiography at
seven weeks and six months as well as clinical follow-up at
two years. Immediately after stent deployment, QCA
showed absence of systolic compression, and all flow abnor-
malities including abrupt early diastolic flow acceleration,
rapid mid-diastolic deceleration and mid-to-late plateau,
and retrograde flow during systole were normalized. At
seven weeks, QCA showed in-stent restenosis in 5 of 11
patients (46%). Four underwent repeat target lesion revas-
cularization; two received coronary angioplasty and two
underwent coronary bypass surgery with an internal mam-
mary artery graft to the LAD. At two years, all remained
free of angina and cardiac events. As stated by the investi-
gators, the incidence of in-stent restenosis in these patients
Figure 3. Intravascular ultrasound imaging of the myocardial bridging in
diastole (A) and in systole (B). A typical half-moon-shaped echolucent area
surrounds the bridge during the entire cardiac cycle (arrows). Note the
catheter artifact in diastole (A) at seven o’clock.
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was not different from that of lesions of 25-mm length and
relatively small-vessel calibers in coronary patients (Table 1).
Long-term studies are necessary to evaluate the stability
of stent geometry, in-stent restenosis, and clinical outcome
in these patients.
Surgical treatment. Before the current era of coronary
stenting, surgical myotomy was regarded as perhaps the
treatment of choice for patients with persistent symptoms
despite intensive medical therapy. Indeed, cleavage of the
overlying muscle fibers eliminates the phasic compression of
the coronary vessel. Thus, supra-arterial myotomy for myo-
cardial bridging and milking effect of the LAD was reported
by several surgical centers (42–45). However, this approach
is more invasive than that of a catheter-based intervention
and probably also carries a higher risk of postprocedural
complications. In addition, the unpredictable intramural
course of the coronary artery may require deep incision of
the ventricular wall, potentially leading to subsequent ven-
tricular wall aneurysm. Alternatively, internal mammary
artery anastomosis to the LAD may be the treatment of
choice in patients with unsuccessful coronary stenting or
in-stent restenosis (16). Likewise, patients with significant
coronary disease in other vessels who require coronary
bypass surgery might be suitable candidates for internal
mammary artery grafting.
Conclusions. Recent techniques available in the cardiac
catheterization laboratory, such as QCA, IVUS, and intra-
coronary Doppler, have shown that significant myocardial
bridging of a coronary artery, especially the LAD, is
characterized by the following morphological and hemody-
namic alterations: 1) phasic systolic vessel compression; 2)
persistent diastolic lumen diameter reduction; 3) increased
blood flow velocities; 4) retrograde systolic flow; and 5)
reduced CFR. These alterations, particularly in association
with aggravating factors such as increased heart rate, de-
creased systolic blood pressure, and coronary vasospasm,
may explain the occurrence of symptoms and myocardial
ischemia in patients with symptomatic MB. As a rule, these
patients present with symptoms and signs of ischemia, as
well as a prior history of unstable angina and non–Q-wave
AMI in some patients. In this respect, they are not
strikingly different from patients with significant single-
vessel coronary disease. The severity of coronary vessel
narrowing during both systole and diastole can be estab-
lished by QCA and IVUS and the degree of flow velocity
acceleration by intracoronary Doppler. In addition, highly
specific morphological and flow velocity patterns include the
“half moon” phenomenon on IVUS and the “finger tip”
phenomenon on intracoronary Doppler. Finally, the treat-
ment options include medical therapy in the majority of
patients and stent implantation, surgical myotomy, or in-
ternal mammary artery bypass grafting in patients with
persistent symptoms despite medical therapy. The long-
term outcome of such interventions, however, is not well
known and requires further study.
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